Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2021 Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Metaphore1 role
Antibody medicines that do more. Metaphore's platform brings together live-cell experimentation and AI/ML to understand how biological…
Neural ConceptVenture round $100M · 9 mo ago • Founded 2018 • 51-200 employees • 34 roles
Meeting the challenges faced by today's engineering organizations requires making computer-based intelligence the central paradigm of…
Aluwave develops advanced lighting & electronic solutions for demanding environments, with LED expertise and great engineering precision.
Proactively accelerate revenue from self-service users without spreadsheets, dashboards, or favors from engineering.
InsightsVenture round $4M · 8 yr ago
Citeline is the leading provider of drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech…
NTS Group develops and manufactures complex opto-mechatronic modules for semiconductor and analytical equipment builders. It combines…

Overview

Engineering Precision Pharmacology. Current paradigm of drug discovery favors designs that target a single biological mechanism.

News

News Nature 2 years ago
Leveraging multiple data types for improved compound-kinase bioactivity prediction
Machine learning provides efficient ways to map compound-kinase interactions. However, diverse bioactivity data types, including single-dose and multi-dose-response assay results, present challenges. Traditional models utilize only multi-dose data, overlo
Read more
Report
Report